"At DermEffects, Royal College-Certified Dr. Wei Jing Loo combines her many years of cosmetic and dermatology experience with her passion for aesthetics. Serving men and women in the London, Ontario area and beyond, Dr. Loo’s most popular procedures include BOTOX Cosmetic®, dermal fillers, laser skin rejuvenation, and RF microneedling treatments. For more information and a full list of services offered, please visit her website today."

During the past decade, DermEffects conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 8 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 8 clinical trials were completed. i.e. 61.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "DermEffects" #1 sponsor was "Amgen" with 4 trials, followed by "Pfizer" with 4 trials sponsored, "Concert Pharmaceuticals" with 3 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored and "ASLAN Pharmaceuticals" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "DermEffects" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "DermEffects" are "Atopic Dermatitis" (5 trials), "Psoriasis" (4 trials), "Alopecia Areata" (3 trials), "Plaque Psoriasis" (3 trials) and "Acne Inversa" (1 trials). Many other conditions were trialed in "DermEffects" in a lesser frequency.

Most popular intervention types in "DermEffects" are "Drug" (19 trials), "Other" (3 trials), "Biological" (1 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Apremilast" (2 trials), "BMS-986165" (2 trials), "CTP-543" (2 trials) and "ABP 501" (1 trials). Other intervention names were less common.

The vast majority of trials in "DermEffects" are 19 trials for "All" genders.

Currently, there are NaN active trials in "DermEffects". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 12 completed trials in DermEffects, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in DermEffects, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".